2011 Globalization Pharmaceuticals Technology 
Strategy Driven
JULY 13, 2011
Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). Copyright (c) 2011. As with the other measures, what is important varies by industry.
Harvard Business Review
SEPTEMBER 14, 2011
We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Tata Motors appointed Tim Leverthon, who previously led R&D at BMW, as head of its global R&D.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
JUNE 16, 2016
Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. Draetta of IACS has found many of the same issues arise in pharmaceutical research.
Harvard Business Review
MARCH 2, 2011
Meanwhile behemoths such as McKinsey and BCG, to maintain their above-industry-average growth rates and keep their global office networks humming, have broadened what they do and moved down the food chain. Monitor & Co., co-founded by Michael Porter back in the early 1980s, has seen better days.
Harvard Business Review
DECEMBER 20, 2011
The two biggest product stories of 2011 were arguably Lipitor and the iPhone 4S. The iPhone 4S's story seems to be about a new beginning: the highly anticipated launch of the latest version of a blockbuster consumer-technology product. Technology observers were initially underwhelmed by the iPhone 4S. Both Pfizer and.
Harvard Business Review
JANUARY 26, 2011
Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. His friend, Dr. Shiping Liu, founder and CEO of Global Business Intelligence Consulting Co., Daniela Saltzman is an MBA student at HBS, class of 2011. Stay tuned. Eccles is a professor of management practice at HBS.
Strategy Driven
MARCH 18, 2011
Large downturns (such as this recession), technology disruptions, or regulatory shifts create discontinuities that simply accelerate the industry’s evolution toward this equilibrium state. He works with global Fortune 500 companies to help them achieve major business transformations. Copyright 2007-2011 by StrategyDriven, Inc.
Expert insights. Personalized for you.
62 
Let's personalize your content